Tag: COVID-19

FDA issues Class 1 recall of COVID-19 rapid test

Editor's Note The Food and Drug Administration (FDA) announced on March 28 a Class 1 recall of the Point of Care Celltrion DiaTrust COVID-19 Ag Rapid Test “because it may have been distributed to unauthorized laboratories,” the American Hospital Association (AHA) May 2 reports. A Class 1 recall is “the…

Read More

By: Tarsilla Moura
May 3, 2022
Share

CDC: Comparison of COVID-19 home antigen test with RT-PCR, viral culture

Editor's Note This study, led by researchers from the Centers for Disease Control and Prevention (CDC), finds that symptomatic individuals with an initial negative home antigen test should test again 1 to 2 days later because test sensitivity peaks several days after COVID-19 onset. In 225 adults and children with…

Read More

By: Judy Mathias
May 3, 2022
Share

Study: COVID-19 vaccine effectiveness in children varies by age, variant

Editor's Note According to a multi-institutional study from the Centers for Disease Control and Prevention, titled “Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years” and published on March 18, two doses of the Pfizer-BioNTech COVID-19 vaccine…

Read More

By: Tarsilla Moura
May 2, 2022
Share

Happy National Nurses Month

Editor's Note In 2020, the American Nurses Association expanded National Nurses Week to National Nurses Month to increase opportunities to elevate and celebrate nursing. National Nurses Week begins on May 6 and ends on May 12, Florence Nightingale’s birthday. The theme this year is “Nurses Make a Difference.” The American…

Read More

By: Judy Mathias
May 2, 2022
Share

African Americans views on COVID-19 testing, contact tracing

Editor's Note This study from Meharry Medical College, Nashville, Tennessee, finds that COVID-19 testing and contact tracing are beneficial among African Americans, but mistrust, COVID-19 stigma, location, and perceived costs are major barriers. Of 62 study participants, the majority (69.4%) were female, had never been tested (62.9%), and had an…

Read More

By: Judy Mathias
May 2, 2022
Share

Joint Commission approves COVID-19 vaccination standard for HCWs

Editor's Note In response to the Centers for Medicare & Medicaid Services (CMS) interim final rule regarding COVID-19 vaccinations for healthcare workers (HCWs), The Joint Commission has approved a new Infection Prevention and Control (IC) Standard IC.02.04.02 and new elements of performance, the regulator announced on April 27. The new…

Read More

By: Tarsilla Moura
April 29, 2022
Share

Dr Fauci explains ‘out of the pandemic phase’ comment

Editor's Note Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and chief medical advisor to President Joe Biden, said in an April 26 interview with PBS NewsHour that "we are certainly right now in this country out of the pandemic phase,"…

Read More

By: Tarsilla Moura
April 28, 2022
Share

CA hospitals lost some $20 billion during pandemic

Editor's Note According to a Kaufman Hall study, titled "Analysis: California Hospitals Endured Significant Financial Strain in 2021," published on April 19, and commissioned by the California Hospital Association, California hospitals collectively lost nearly $6 billion, “roughly three times the $2.2 billion that had been projected,” in 2021 and $14…

Read More

By: Tarsilla Moura
April 27, 2022
Share

CDC report: Nearly 60% of Americans have had COVID-19

Editor's Note According to a Centers for Disease Control and Prevention (CDC) report, titled “Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022” and published on April 26, almost 60% of people living in the US, including 75% of children and adolescents, has contracted COVID-19, Becker’s Hospital Review…

Read More

By: Tarsilla Moura
April 27, 2022
Share

Lower dosing of COVID-19 vaccine could save lives in a supply shortage

Editor's Note A study, titled “Modeling comparative cost-effectiveness of SARS-CoV-2 vaccine dose fractionation in India” and published in February 2022 by Nature Media, found that administering smaller doses of the COVID-19 vaccines may be an economically viable way to save more lives than either fully vaccinating or not vaccinating in…

Read More

By: Tarsilla Moura
April 25, 2022
Share
Live chat by BoldChat